Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Furberg

Showing results (1-10 of 205) with videos related to

Pageof 21
Sort By:
Journal of Human Hypertension|May 31, 2002
Doxazosin, an inferior antihypertensive agent?C D Furberg
Katilolehti|June 1, 1981
[Hypertension in the aged]C D Furberg
Clinical Cardiology|July 14, 2000
Class effects and evidence-based medicineC D Furberg
Circulation|March 1, 1993
Can we measure and predict atherosclerotic progression?C D Furberg
Arzneimittel-Forschung|August 1, 1989
The impact of clinical trials on clinical practiceC D Furberg
The American Journal of Cardiology|February 1, 1984
Clinical value of intracoronary streptokinaseC D Furberg
Circulation|January 20, 1999
Natural statins and stroke riskC D Furberg
Evidence-Based Cardiovascular Medicine|April 1, 1997
School and home interventions improved children's dietary and physical activity behaviorsC D Furberg
American Heart Journal|December 1, 1994
Lipid-lowering trials: results and limitationsC D Furberg
Preventive Medicine|September 1, 1994
Challenges to the funding of prevention researchC D Furberg
Pageof 21

Showing results (1-10 of 205) with videos related to

Sort By:
Pageof 21
Journal of Human Hypertension|May 31, 2002
Doxazosin, an inferior antihypertensive agent?C D Furberg
Katilolehti|June 1, 1981
[Hypertension in the aged]C D Furberg
Clinical Cardiology|July 14, 2000
Class effects and evidence-based medicineC D Furberg
Circulation|March 1, 1993
Can we measure and predict atherosclerotic progression?C D Furberg
Arzneimittel-Forschung|August 1, 1989
The impact of clinical trials on clinical practiceC D Furberg
The American Journal of Cardiology|February 1, 1984
Clinical value of intracoronary streptokinaseC D Furberg
Circulation|January 20, 1999
Natural statins and stroke riskC D Furberg
Evidence-Based Cardiovascular Medicine|April 1, 1997
School and home interventions improved children's dietary and physical activity behaviorsC D Furberg
American Heart Journal|December 1, 1994
Lipid-lowering trials: results and limitationsC D Furberg
Preventive Medicine|September 1, 1994
Challenges to the funding of prevention researchC D Furberg
Pageof 21